SRx Health receives NYSE American deficiency notice for stockholders' equity below $4M

SRx Health Solutions, Inc.

Received NYSE American notice on Oct 14, 2025 for non-compliance with Section 1003(a)(ii) due to stockholders' equity below $4M and net losses.
Company must submit compliance plan by Nov 13, 2025 and cure deficiency by July 14, 2026.
No immediate delisting; common stock continues trading on NYSE American under symbol SRXH.
Company is actively developing measures to regain compliance within the cure period.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.